首页> 外国专利> Pluripotent stem cell isolated from umbilical cord blood and cell therapeutic agent for treating ischemic necrosis disease containing the same

Pluripotent stem cell isolated from umbilical cord blood and cell therapeutic agent for treating ischemic necrosis disease containing the same

机译:从脐带血分离的多能干细胞和用于治疗多能干细胞的缺血性坏死疾病

摘要

The present invention relates to multipotent stem cells, adult stem cells isolated by culturing umbilical cord blood in a medium containing human serum or plasma, and a cellular therapeutic agent for ischemic necrosis resulting from occlusive arterial disease, which contains the multipotent stem cells as active ingredients. The multipotent stem cells according to the invention have ability to differentiate into osteogenic cells or nerve cells, even if they are adult stem cells. Thus, the multipotent stem cells will be useful for the treatment of not only diseases where the stagnation of femoral arterial circulation causes peripheral circulatory disorders to degrade microvascular tissue, leading to ischemic necrosis, but also ischemic diseases, such as cerebral infarction, myocardial infarction and the necrosis of limb ends resulting from diabetic sequelae.
机译:本发明涉及多能干细胞,通过在含有人血清或血浆的培养基中培养脐带血而分离的成年干细胞以及由闭塞性动脉疾病引起的缺血性坏死的细胞治疗剂,其含有多能干细胞作为有效成分。 。即使本发明的多能干细胞是成年干细胞,它们也具有分化为成骨细胞或神经细胞的能力。因此,多能干细胞不仅可用于治疗股动脉循环停滞导致外周循环障碍导致微血管组织降解,导致缺血性坏死的疾病,还可用于治疗缺血性疾病,例如脑梗死,心肌梗塞和糖尿病后遗症导致肢端坏死。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号